Insider Trading activities of Aimmune Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aimmune Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aimmune Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aimmune Therapeutics, Inc. since 2005. The reporting company's ticker symbol is AIMT. The reporting company's CIK number is 1631650.
The total value of stock buying since 2005 is $33,285,407.
The total value of stock sales since 2005 is $42,185,755.
The total value of stock option exercises since 2005 is $4,140,244.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aimmune Therapeutics, Inc. (AIMT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-06 1,600 $48,662 300,000 $9,529,222 300,000 $906,598
2018-05 0 $0 3,296 $108,768 3,296 $42,683
2018-03 0 $0 5,330 $187,953 5,330 $62,849
2018-02 67,468 $2,158,976 8,240 $291,573 8,240 $41,262
2018-01 0 $0 121,831 $4,655,756 121,831 $725,122
2017-12 0 $0 82,074 $3,205,920 82,074 $325,758
2017-11 0 $0 5,655 $201,615 5,655 $98,281
2017-10 0 $0 257,425 $8,113,611 57,425 $887,053
2017-09 0 $0 178,390 $4,330,410 78,390 $321,172
2017-07 0 $0 139,070 $2,943,643 81,610 $246,623
2017-06 0 $0 49,400 $998,571 0 $0
2017-05 5,000 $99,210 600 $12,090 0 $0
2017-04 0 $0 15,000 $323,730 15,000 $45,330
2017-03 0 $0 10,000 $229,500 10,000 $30,219
2017-01 0 $0 0 $0 20,681 $62,497
2016-11 0 $0 109,096 $2,474,673 59,096 $178,587
2016-10 0 $0 25,000 $420,000 25,000 $75,550
2016-09 0 $0 30,000 $504,000 30,000 $90,660
2016-05 0 $0 240,000 $3,654,720 0 $0
2016-03 235,512 $3,255,480 0 $0 0 $0
2015-08 1,666,680 $27,723,079 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aimmune Therapeutics, Inc. insiders (AIMT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-06-13 Bjerkholt Eric (Chief Financial Officer) Buy 1,600 30.41 48,662
2018-06-11 Dilly Stephen George (President and CEO) Sale 29,457 30.84 908,306
2018-06-11 Dilly Stephen George (President and CEO) Option Ex 29,457 3.02 89,019
2018-06-08 Dilly Stephen George (President and CEO) Sale 42,106 30.70 1,292,527
2018-06-08 Dilly Stephen George (President and CEO) Option Ex 42,106 3.02 127,244
2018-06-07 Dilly Stephen George (President and CEO) Sale 32,598 31.26 1,019,111
2018-06-07 Dilly Stephen George (President and CEO) Option Ex 32,598 3.02 98,511
2018-06-06 Dilly Stephen George (President and CEO) Sale 30,465 31.20 950,386
2018-06-06 Dilly Stephen George (President and CEO) Option Ex 30,465 3.02 92,065
2018-06-05 Dilly Stephen George (See Remarks) Sale 38,825 31.83 1,235,838
2018-06-05 Dilly Stephen George (See Remarks) Option Ex 38,825 3.02 117,329
2018-06-04 Dilly Stephen George (See Remarks) Sale 65,352 32.29 2,110,346
2018-06-04 Dilly Stephen George (See Remarks) Option Ex 65,352 3.02 197,493
2018-06-01 Dilly Stephen George (See Remarks) Sale 61,197 32.89 2,012,708
2018-06-01 Dilly Stephen George (See Remarks) Option Ex 61,197 3.02 184,937
2018-05-22 Sheehy Douglas T. (See Remarks) Sale 3,296 33.00 108,768
2018-05-22 Sheehy Douglas T. (See Remarks) Option Ex 3,296 12.95 42,683
2018-03-05 Sheehy Douglas T. (See Remarks) Sale 3,523 36.37 128,142
2018-03-05 Sheehy Douglas T. (See Remarks) Option Ex 3,523 16.29 57,389
2018-03-01 Rozenman Mary M. (See Remarks) Sale 1,807 33.10 59,811
2018-03-01 Rozenman Mary M. (See Remarks) Option Ex 1,807 3.02 5,460
2018-02-26 Iwicki Mark T (Director) Buy 9,375 32.00 300,000
2018-02-26 Falberg Kathryn E (Director) Buy 30,000 32.00 960,000
2018-02-26 Bjerkholt Eric (Chief Financial Officer) Buy 3,125 32.00 100,000
2018-02-22 Tammenoms Bakker Juliet (10% Owner) Buy 9,375 32.00 300,000
2018-02-22 Enright Patrick G (Director) Buy 15,593 32.00 498,976
2018-02-05 Sheehy Douglas T. (See Remarks) Sale 1,648 35.87 59,113
2018-02-05 Sheehy Douglas T. (See Remarks) Option Ex 1,648 12.95 21,341
2018-02-01 Rozenman Mary M. (See Remarks) Sale 6,592 35.26 232,460
2018-02-01 Rozenman Mary M. (See Remarks) Option Ex 6,592 3.02 19,921
2018-01-24 Sheehy Douglas T. (See Remarks) Sale 1,875 38.15 71,531
2018-01-24 Sheehy Douglas T. (See Remarks) Option Ex 1,875 19.63 36,806
2018-01-16 Adelman Daniel C Md (Chief Medical Officer) Sale 9,933 40.00 397,320
2018-01-16 Adelman Daniel C Md (Chief Medical Officer) Option Ex 9,933 11.45 113,732
2018-01-12 Adelman Daniel C Md (Chief Medical Officer) Sale 26,784 40.00 1,071,360
2018-01-12 Adelman Daniel C Md (Chief Medical Officer) Option Ex 26,784 11.45 306,676
2018-01-04 Sheehy Douglas T. (See Remarks) Sale 1,648 37.33 61,519
2018-01-04 Sheehy Douglas T. (See Remarks) Option Ex 1,648 12.95 21,341
2018-01-02 Barrowcliffe Susan E. (General Manager, Europe) Sale 75,000 37.46 2,809,500
2018-01-02 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 75,000 3.02 226,649
2018-01-02 Rozenman Mary M. (See Remarks) Sale 6,591 37.10 244,526
2018-01-02 Rozenman Mary M. (See Remarks) Option Ex 6,591 3.02 19,918
2017-12-27 Adelman Daniel C Md (Chief Medical Officer) Sale 3,283 40.00 131,320
2017-12-27 Adelman Daniel C Md (Chief Medical Officer) Option Ex 3,283 11.45 37,590
2017-12-26 Rozenman Mary M. (See Remarks) Sale 75,010 39.02 2,926,965
2017-12-26 Rozenman Mary M. (See Remarks) Option Ex 75,010 3.02 226,680
2017-12-26 Sheehy Douglas T. (See Remarks) Sale 1,875 39.44 73,950
2017-12-26 Sheehy Douglas T. (See Remarks) Option Ex 1,875 19.63 36,806
2017-12-04 Sheehy Douglas T. (See Remarks) Sale 1,906 38.66 73,685
2017-12-04 Sheehy Douglas T. (See Remarks) Option Ex 1,906 12.95 24,682
2017-11-30 Sheehy Douglas T. (See Remarks) Sale 3,750 37.00 138,750
2017-11-30 Sheehy Douglas T. (See Remarks) Option Ex 3,750 19.63 73,612
2017-11-09 Sheehy Douglas T. (See Remarks) Sale 1,905 33.00 62,865
2017-11-09 Sheehy Douglas T. (See Remarks) Option Ex 1,905 12.95 24,669
2017-10-23 Sheehy Douglas T. (See Remarks) Sale 47,425 35.07 1,663,242
2017-10-23 Sheehy Douglas T. (See Remarks) Option Ex 47,425 16.29 772,553
2017-10-23 Dilly Stephen George (See Remarks) Sale 100,000 34.83 3,483,100
2017-10-23 Adelman Daniel C Md (Chief Medical Officer) Sale 10,000 34.33 343,260
2017-10-23 Adelman Daniel C Md (Chief Medical Officer) Option Ex 10,000 11.45 114,500
2017-10-16 Dilly Stephen George (President and CEO) Sale 1,154 26.24 30,278
2017-10-06 Dilly Stephen George (President and CEO) Sale 4,047 26.31 106,468
2017-10-05 Dilly Stephen George (President and CEO) Sale 14,689 26.24 385,498
2017-10-04 Dilly Stephen George (President and CEO) Sale 80,110 26.24 2,101,765
2017-09-25 Barrowcliffe Susan E. (General Manager, Europe) Sale 20,000 25.00 500,000
2017-09-25 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 20,000 3.02 60,439
2017-09-25 Dilly Stephen George (President and CEO) Sale 100,000 25.01 2,500,800
2017-09-25 Adelman Daniel C Md (Chief Medical Officer) Sale 10,000 25.00 250,000
2017-09-25 Adelman Daniel C Md (Chief Medical Officer) Option Ex 10,000 11.45 114,500
2017-09-07 Rozenman Mary M. (See Remarks) Sale 30,000 22.50 675,000
2017-09-07 Rozenman Mary M. (See Remarks) Option Ex 30,000 3.02 90,660
2017-09-06 Barrowcliffe Susan E. (General Manager, Europe) Sale 15,167 22.00 333,704
2017-09-06 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 15,167 3.02 45,834
2017-09-05 Barrowcliffe Susan E. (General Manager, Europe) Sale 3,223 22.00 70,906
2017-09-05 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 3,223 3.02 9,739
2017-07-27 Barrowcliffe Susan E. (General Manager, Europe) Sale 500 22.00 11,000
2017-07-27 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 500 3.02 1,511
2017-07-26 Dilly Stephen George (President and CEO) Sale 50,000 21.46 1,073,100
2017-07-25 Barrowcliffe Susan E. (General Manager, Europe) Sale 4,650 22.00 102,300
2017-07-25 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 4,650 3.02 14,052
2017-07-24 Barrowcliffe Susan E. (General Manager, Europe) Sale 500 22.00 11,000
2017-07-24 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 500 3.02 1,511
2017-07-21 Barrowcliffe Susan E. (General Manager, Europe) Sale 960 22.00 21,120
2017-07-21 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 960 3.02 2,901
2017-07-21 Sheehy Douglas T. (See Remarks) Sale 7,460 21.66 161,561
2017-07-17 Rozenman Mary M. (See Remarks) Sale 300 21.38 6,414
2017-07-17 Rozenman Mary M. (See Remarks) Option Ex 300 3.02 906
2017-07-14 Rozenman Mary M. (See Remarks) Sale 5,666 21.39 121,173
2017-07-14 Rozenman Mary M. (See Remarks) Option Ex 5,666 3.02 17,122
2017-07-13 Rozenman Mary M. (See Remarks) Sale 8,974 21.47 192,662
2017-07-13 Rozenman Mary M. (See Remarks) Option Ex 8,974 3.02 27,119
2017-07-05 Rozenman Mary M. (See Remarks) Sale 15,060 21.39 322,208
2017-07-05 Rozenman Mary M. (See Remarks) Option Ex 15,060 3.02 45,511
2017-07-03 Barrowcliffe Susan E. (General Manager, Europe) Sale 15,000 20.26 303,915
2017-07-03 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 15,000 3.02 45,330
2017-07-03 Rozenman Mary M. (See Remarks) Sale 30,000 20.57 617,190
2017-07-03 Rozenman Mary M. (See Remarks) Option Ex 30,000 3.02 90,660
2017-06-23 Dilly Stephen George (President and CEO) Sale 49,400 20.21 998,571
2017-05-12 Bjerkholt Eric (Chief Financial Officer) Buy 5,000 19.84 99,210
2017-05-10 Dilly Stephen George (See Remarks) Sale 600 20.15 12,090
2017-04-03 Desouza Warren L. (Chief Financial Officer) Sale 15,000 21.58 323,730
2017-04-03 Desouza Warren L. (Chief Financial Officer) Option Ex 15,000 3.02 45,330
2017-03-21 Desouza Warren L. (Chief Financial Officer) Sale 10,000 22.95 229,500
2017-03-21 Desouza Warren L. (Chief Financial Officer) Option Ex 10,000 3.02 30,219
2017-01-11 Desouza Warren L. (Chief Financial Officer) Option Ex 20,681 3.02 62,497
2016-11-11 Barrowcliffe Susan E. (General Manager, Europe) Sale 20,000 25.00 500,000
2016-11-11 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 20,000 3.02 60,439
2016-11-11 Dilly Stephen George (See Remarks) Sale 48,696 25.01 1,217,984
2016-11-10 Dilly Stephen George (See Remarks) Sale 1,304 25.00 32,600
2016-11-08 Barrowcliffe Susan E. (General Manager, Europe) Sale 15,000 20.00 300,000
2016-11-08 Barrowcliffe Susan E. (General Manager, Europe) Option Ex 15,000 3.02 45,330
2016-11-04 Rozenman Mary M. (See Remarks) Sale 24,096 17.60 424,089
2016-11-04 Rozenman Mary M. (See Remarks) Option Ex 24,096 3.02 72,818
2016-10-05 Rozenman Mary M. (See Remarks) Sale 25,000 16.80 420,000
2016-10-05 Rozenman Mary M. (See Remarks) Option Ex 25,000 3.02 75,550
2016-09-08 Rozenman Mary M. (See Remarks) Sale 30,000 16.80 504,000
2016-09-08 Rozenman Mary M. (See Remarks) Option Ex 30,000 3.02 90,660
2016-05-31 Tananbaum James B. (10% Owner) Sale 240,000 15.23 3,654,720
2016-03-29 Enright Patrick G (Director) Buy 157,008 13.82 2,170,320
2015-08-24 Tananbaum James B. (10% Owner) Buy 25,485 19.66 500,907
2015-08-11 Tananbaum James B. (10% Owner) Buy 642,035 17.50 11,235,612
2015-08-11 Iwicki Mark T (Director) Buy 20,000 16.00 320,000
2015-08-11 Enright Patrick G (Director) Buy 625,000 16.00 10,000,000
2015-08-11 Mcdade Mark (Director) Buy 16,660 16.00 266,560
2015-08-11 Falberg Kathryn E (Director) Buy 25,000 16.00 400,000

Insider trading activities including stock purchases, stock sales, and option exercises of AIMT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aimmune Therapeutics, Inc. (symbol AIMT, CIK number 1631650) see the Securities and Exchange Commission (SEC) website.